BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bjerrum S, Schiller I, Dendukuri N, Kohli M, Nathavitharana RR, Zwerling AA, Denkinger CM, Steingart KR, Shah M. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev 2019;10:CD011420. [PMID: 31633805 DOI: 10.1002/14651858.CD011420.pub3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Matoga MM, Bisson GP, Gupta A, Miyahara S, Sun X, Fry C, Manabe YC, Kumwenda J, Cecilia K, Nyirenda M, Ngongondo M, Mbewe A, Lagat D, Wallis C, Mugerwa H, Hosseinipour MC. Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy. Clin Infect Dis 2021;73:e870-7. [PMID: 34398958 DOI: 10.1093/cid/ciab179] [Reference Citation Analysis]
2 Ignatius EH, Cohen KA, Bishai WR. Getting to the point in point-of-care diagnostics for tuberculosis. J Clin Invest 2020;130:5671-3. [PMID: 32986020 DOI: 10.1172/JCI142497] [Reference Citation Analysis]
3 Arshad A, Dayal S, Gadhe R, Mawley A, Shin K, Tellez D, Phan P, Venketaraman V. Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment. J Clin Med 2020;9:E2962. [PMID: 32937808 DOI: 10.3390/jcm9092962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger CM, Schumacher SG, Steingart KR. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2021;1:CD012768. [PMID: 33448348 DOI: 10.1002/14651858.CD012768.pub3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
5 Vonasek B, Ness T, Takwoingi Y, Kay AW, van Wyk SS, Ouellette L, Marais BJ, Steingart KR, Mandalakas AM. Screening tests for active pulmonary tuberculosis in children. Cochrane Database Syst Rev 2021;6:CD013693. [PMID: 34180536 DOI: 10.1002/14651858.CD013693.pub2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Greyling R, Meintjes G, Sossen B. Alere Determine-tuberculosis lipoarabinomannan positivity in disseminated non-tuberculous mycobacteria: An illustrative case series. Southern African Journal of HIV Medicine 2022;23. [DOI: 10.4102/sajhivmed.v23i1.1369] [Reference Citation Analysis]
7 Comella-Del-Barrio P, Bimba JS, Adelakun R, Kontogianni K, Molina-Moya B, Osazuwa O, Creswell J, Cuevas LE, Domínguez J. Fujifilm SILVAMP TB-LAM for the Diagnosis of Tuberculosis in Nigerian Adults. J Clin Med 2021;10:2514. [PMID: 34204120 DOI: 10.3390/jcm10112514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 van Hoving DJ, Meintjes G, Maartens G, Kengne AP. A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre. Wellcome Open Res 2020;5:72. [DOI: 10.12688/wellcomeopenres.15824.2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lange C, Aarnoutse R, Chesov D, van Crevel R, Gillespie SH, Grobbel HP, Kalsdorf B, Kontsevaya I, van Laarhoven A, Nishiguchi T, Mandalakas A, Merker M, Niemann S, Köhler N, Heyckendorf J, Reimann M, Ruhwald M, Sanchez-Carballo P, Schwudke D, Waldow F, DiNardo AR. Perspective for Precision Medicine for Tuberculosis. Front Immunol 2020;11:566608. [PMID: 33117351 DOI: 10.3389/fimmu.2020.566608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kerkhoff AD, Longley N, Kelly N, Cross A, Vogt M, Wood R, Hermans S, Lawn SD, Harrison TS. Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa. BMC Infect Dis 2020;20:555. [PMID: 32736601 DOI: 10.1186/s12879-020-05227-9] [Reference Citation Analysis]
11 Kebede W, Abebe G, Gudina EK, Van Rie A. The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study. Sci Rep 2021;11:24428. [PMID: 34952913 DOI: 10.1038/s41598-021-04090-1] [Reference Citation Analysis]
12 Quinn CM, Poplin V, Kasibante J, Yuquimpo K, Gakuru J, Cresswell FV, Bahr NC. Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease. Life (Basel) 2020;10:E262. [PMID: 33138069 DOI: 10.3390/life10110262] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Bulterys MA, Wagner B, Redard-Jacot M, Suresh A, Pollock NR, Moreau E, Denkinger CM, Drain PK, Broger T. Point-Of-Care Urine LAM Tests for Tuberculosis Diagnosis: A Status Update. J Clin Med 2019;9:E111. [PMID: 31906163 DOI: 10.3390/jcm9010111] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
14 Kay AW, González Fernández L, Takwoingi Y, Eisenhut M, Detjen AK, Steingart KR, Mandalakas AM. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev 2020;8:CD013359. [PMID: 32853411 DOI: 10.1002/14651858.CD013359.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
15 MacGregor-Fairlie M, Wilkinson S, Besra GS, Goldberg Oppenheimer P. Tuberculosis diagnostics: overcoming ancient challenges with modern solutions. Emerg Top Life Sci 2020;4:423-36. [PMID: 33258943 DOI: 10.1042/ETLS20200335] [Reference Citation Analysis]
16 Broger T, Nicol MP, Székely R, Bjerrum S, Sossen B, Schutz C, Opintan JA, Johansen IS, Mitarai S, Chikamatsu K, Kerkhoff AD, Macé A, Ongarello S, Meintjes G, Denkinger CM, Schumacher SG. Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data. PLoS Med 2020;17:e1003113. [PMID: 32357197 DOI: 10.1371/journal.pmed.1003113] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
17 Abdulgader SM, Okunola AO, Ndlangalavu G, Reeve BWP, Allwood BW, Koegelenberg CFN, Warren RM, Theron G. Diagnosing Tuberculosis: What Do New Technologies Allow Us to (Not) Do? Respiration 2022;:1-17. [PMID: 35760050 DOI: 10.1159/000525142] [Reference Citation Analysis]
18 Meier NR, Battegay M, Ottenhoff THM, Furrer H, Nemeth J, Ritz N. HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens. Front Immunol 2021;12:620622. [PMID: 33777000 DOI: 10.3389/fimmu.2021.620622] [Reference Citation Analysis]
19 Broger T, Nicol MP, Sigal GB, Gotuzzo E, Zimmer AJ, Surtie S, Caceres-Nakiche T, Mantsoki A, Reipold EI, Székely R, Tsionsky M, van Heerden J, Plisova T, Chikamatsu K, Lowary TL, Pinter A, Mitarai S, Moreau E, Schumacher SG, Denkinger CM. Diagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients. J Clin Invest 2020;130:5756-64. [PMID: 32692731 DOI: 10.1172/JCI140461] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
20 Flores J, Cancino JC, Chavez-Galan L. Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It? Front Microbiol 2021;12:638047. [PMID: 33935997 DOI: 10.3389/fmicb.2021.638047] [Reference Citation Analysis]
21 Huerga H, Cossa L, Manhiça I, Bastard M, Telnov A, Molfino L, Sanchez-Padilla E. Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients. Am J Trop Med Hyg 2020;102:562-6. [PMID: 31971152 DOI: 10.4269/ajtmh.19-0493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Singhroy DN, MacLean E, Kohli M, Lessem E, Branigan D, England K, Suleiman K, Drain PK, Ruhwald M, Schumacher S, Denkinger CM, Waning B, Van Gemert W, Pai M. Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers. Gates Open Res 2020;4:24. [PMID: 32185366 DOI: 10.12688/gatesopenres.13112.2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
23 Roberts T, Sahu S, Malar J, Abdullaev T, Vandevelde W, Pillay YG, Fujiwara PI, Reid A, Hader S, Singh S, Kamarulzaman A, Ahmedov S. Turning threats into opportunities: how to implement and advance quality TB services for people with HIV during the COVID-19 pandemic and beyond. J Int AIDS Soc 2021;24:e25696. [PMID: 33787058 DOI: 10.1002/jia2.25696] [Reference Citation Analysis]
24 Jakhar S, Bitzer AA, Stromberg LR, Mukundan H. Pediatric Tuberculosis: The Impact of "Omics" on Diagnostics Development. Int J Mol Sci 2020;21:E6979. [PMID: 32977381 DOI: 10.3390/ijms21196979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Tlali M, Fielding KL, Karat AS, Hoffmann CJ, Muravha T, Grant AD, Charalambous S. Sensitivity of the lateral flow urine lipoarabinomannan assay in ambulant adults with advanced HIV disease: data from the TB Fast Track study. Trans R Soc Trop Med Hyg 2020;114:556-60. [PMID: 32313941 DOI: 10.1093/trstmh/traa018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Olbrich L, Khambati N, Bijker EM, Ruhwald M, Heinrich N, Song R. FujiLAM for the diagnosis of childhood tuberculosis: a systematic review. bmjpo 2022;6:e001447. [DOI: 10.1136/bmjpo-2022-001447] [Reference Citation Analysis]
27 Comella-Del-Barrio P, Molina-Moya B, Gautier J, Villar-Hernández R, Doresca MJC, Sallés-Mingels B, Canales-Aliaga L, Narcisse M, Pérez-Porcuna TM, Creswell J, Cuevas LE, Domínguez J. Diagnostic Performance of the Fujifilm SILVAMP TB-LAM in Children with Presumptive Tuberculosis. J Clin Med 2021;10:1914. [PMID: 33925008 DOI: 10.3390/jcm10091914] [Reference Citation Analysis]
28 Ricks S, Denkinger CM, Schumacher SG, Hallett TB, Arinaminpathy N. The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis. PLoS Med 2020;17:e1003466. [PMID: 33306694 DOI: 10.1371/journal.pmed.1003466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 de Vasconcellos K, Ramjathan P, Singh D. The utility of point-of-care urinary lipoarabinomannan testing for the diagnosis of tuberculosis in critically ill patients: a prospective observational study. BMC Infect Dis 2021;21:281. [PMID: 33740905 DOI: 10.1186/s12879-021-05979-y] [Reference Citation Analysis]
30 Vonasek BJ, Radtke KK, Vaz P, Buck WC, Chabala C, McCollum ED, Marcy O, Fitzgerald E, Kondwani A, Garcia-Prats AJ. Tuberculosis in children with severe acute malnutrition. Expert Rev Respir Med 2022. [PMID: 35175880 DOI: 10.1080/17476348.2022.2043747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Simieneh A, Tadesse M, Kebede W, Gashaw M, Abebe G. Combination of Xpert® MTB/RIF and DetermineTM TB-LAM Ag improves the diagnosis of extrapulmonary tuberculosis at Jimma University Medical Center, Oromia, Ethiopia. PLoS One 2022;17:e0263172. [PMID: 35113917 DOI: 10.1371/journal.pone.0263172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Gill CM, Dolan L, Piggott LM, Mclaughlin AM. New developments in tuberculosis diagnosis and treatment. Breathe 2022;18:210149. [DOI: 10.1183/20734735.0149-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Bjerrum S, Broger T, Székely R, Mitarai S, Opintan JA, Kenu E, Lartey M, Addo KK, Chikamatsu K, Macé A, Schumacher SG, Moreau E, Shah M, Johansen IS, Denkinger CM. Diagnostic Accuracy of a Novel and Rapid Lipoarabinomannan Test for Diagnosing Tuberculosis Among People With Human Immunodeficiency Virus. Open Forum Infect Dis 2020;7:ofz530. [PMID: 31976353 DOI: 10.1093/ofid/ofz530] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
34 Oreskovic A, Panpradist N, Marangu D, Ngwane MW, Magcaba ZP, Ngcobo S, Ngcobo Z, Horne DJ, Wilson DPK, Shapiro AE, Drain PK, Lutz BR. Diagnosing Pulmonary Tuberculosis by Using Sequence-Specific Purification of Urine Cell-Free DNA. J Clin Microbiol 2021;59:e0007421. [PMID: 33789959 DOI: 10.1128/JCM.00074-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kainz DM, Breiner BJ, Früh SM, Hutzenlaub T, Zengerle R, Paust N. Eliminating viscosity bias in lateral flow tests. Microsyst Nanoeng 2021;7:72. [PMID: 34567784 DOI: 10.1038/s41378-021-00296-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Iguchi M, Noguchi Y, Yamamoto S, Tanaka Y, Tsujimoto H. Diagnostic test accuracy of jolt accentuation for headache in acute meningitis in the emergency setting. Cochrane Database Syst Rev 2020;6:CD012824. [PMID: 32524581 DOI: 10.1002/14651858.CD012824.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
37 Bjerrum S, Åhsberg J, Szekely R, Opintan J, Lartey M, Shah M, Mitarai S, Broger T, Ruhwald M, Johansen IS. Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine versus Spot Urine for Diagnosis of Tuberculosis among People with HIV. Microbiol Spectr 2022;:e0020822. [PMID: 35357206 DOI: 10.1128/spectrum.00208-22] [Reference Citation Analysis]
38 Nathavitharana RR, Lederer P, Chaplin M, Bjerrum S, Steingart KR, Shah M. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV. Cochrane Database Syst Rev 2021;8:CD014641. [PMID: 34416013 DOI: 10.1002/14651858.CD014641] [Reference Citation Analysis]
39 Sossen B, Ryan A, Bielawski J, Greyling R, Matthews G, Hurribunce-James S, Goliath R, Caldwell J, Meintjes G. Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha. South Afr J HIV Med 2021;22:1226. [PMID: 34007476 DOI: 10.4102/sajhivmed.v22i1.1226] [Reference Citation Analysis]
40 Bouton TC, Jacobson KR. Symptom Screens Are Not Sufficient: The Fight Against Tuberculosis Needs Better Weapons. Clin Infect Dis 2021;73:121-3. [PMID: 32296819 DOI: 10.1093/cid/ciaa440] [Reference Citation Analysis]
41 Singhroy DN, MacLean E, Kohli M, Lessem E, Branigan D, England K, Suleiman K, Drain PK, Ruhwald M, Schumacher S, Denkinger CM, Waning B, Van Gemert W, Pai M. Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers. Gates Open Res 2020;4:24. [PMID: 32185366 DOI: 10.12688/gatesopenres.13112.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]